Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-015429
Filing Date
2022-05-31
Accepted
2022-05-31 08:05:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 formdefa14a.htm DEFA14A 14292
2 notice_001.jpg GRAPHIC 559208
3 notice_002.jpg GRAPHIC 379643
4 notice_003.jpg GRAPHIC 3119081
5 notice_004.jpg GRAPHIC 579751
  Complete submission text file 0001493152-22-015429.txt   6398299
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39531 | Film No.: 22980558
SIC: 2834 Pharmaceutical Preparations